These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26536229)

  • 1. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
    Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
    PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release.
    Skovdahl HK; Damås JK; Granlund AVB; Østvik AE; Doseth B; Bruland T; Mollnes TE; Sandvik AK
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
    Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
    Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.
    Østvik AE; Granlund AV; Torp SH; Flatberg A; Beisvåg V; Waldum HL; Flo TH; Espevik T; Damås JK; Sandvik AK
    Clin Exp Immunol; 2013 Sep; 173(3):502-11. PubMed ID: 23668802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation.
    Hanna DN; Smith PM; Novitskiy SV; Washington MK; Zi J; Weaver CJ; Hamaamen JA; Lewis KB; Zhu J; Yang J; Liu Q; Beauchamp RD; Means AL
    Gastroenterology; 2022 Nov; 163(5):1334-1350.e14. PubMed ID: 35863523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies.
    Frick VO; Rubie C; Kölsch K; Wagner M; Ghadjar P; Graeber S; Glanemann M
    Scand J Immunol; 2013 Sep; 78(3):298-305. PubMed ID: 23790181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT5A Modulates Chemokine Receptor CCR6 Expression and Enhances Pre-B Cell Growth in a CCL20-Dependent Manner.
    Tsuruyama T; Hiratsuka T; Aini W; Nakamura T
    J Cell Biochem; 2016 Nov; 117(11):2630-42. PubMed ID: 27018255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
    Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
    PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of CCL20 in human inflammatory bowel disease.
    Kaser A; Ludwiczek O; Holzmann S; Moschen AR; Weiss G; Enrich B; Graziadei I; Dunzendorfer S; Wiedermann CJ; Mürzl E; Grasl E; Jasarevic Z; Romani N; Offner FA; Tilg H
    J Clin Immunol; 2004 Jan; 24(1):74-85. PubMed ID: 14997037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ expression of the CCL20-CCR6 axis in lymphocyte-rich gastric cancer and its potential role in the formation of lymphoid stroma.
    Ohtani H; Nakayama T; Yoshie O
    Pathol Int; 2011 Nov; 61(11):645-51. PubMed ID: 22029675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
    Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
    J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
    Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
    J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the chemokine receptor CCR6 in human renal inflammation.
    Welsh-Bacic D; Lindenmeyer M; Cohen CD; Draganovici D; Mandelbaum J; Edenhofer I; Ziegler U; Regele H; Wüthrich RP; Segerer S
    Nephrol Dial Transplant; 2011 Apr; 26(4):1211-20. PubMed ID: 20844183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease.
    Kwon JH; Keates S; Bassani L; Mayer LF; Keates AC
    Gut; 2002 Dec; 51(6):818-26. PubMed ID: 12427784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
    Li Q; Laumonnier Y; Syrovets T; Simmet T
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease.
    Ostvik AE; Granlund Av; Gustafsson BI; Torp SH; Espevik T; Mollnes TE; Damås JK; Sandvik AK
    Inflamm Bowel Dis; 2014 Jun; 20(6):995-1003. PubMed ID: 24739633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues.
    Zhang W; Nie L; Wang Y; Wang XP; Zhao H; Dongol S; Maharjan S; Cheng L
    PLoS One; 2013; 8(6):e66286. PubMed ID: 23823618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CCR6 and CXCR6 by Gut-Derived CD4
    Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
    Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines as novel therapeutic targets for inflammatory bowel disease.
    Nishimura M; Kuboi Y; Muramoto K; Kawano T; Imai T
    Ann N Y Acad Sci; 2009 Sep; 1173():350-6. PubMed ID: 19758172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.
    Giuliani N; Lisignoli G; Colla S; Lazzaretti M; Storti P; Mancini C; Bonomini S; Manferdini C; Codeluppi K; Facchini A; Rizzoli V
    Cancer Res; 2008 Aug; 68(16):6840-50. PubMed ID: 18703490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.